Oppenheimer Asset Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-12,970
Closed -$297K 1197
2025
Q1
$297K Sell
12,970
-3,187
-20% -$76.9K ﹤0.01% 964
2024
Q4
$409K Sell
16,157
-6,821
-30% -$173K 0.01% 912
2024
Q3
$573K Sell
22,978
-9,695
-30% -$287K 0.01% 848
2024
Q2
$969K Buy
32,673
+4,378
+15% +$121K 0.01% 715
2024
Q1
$853K Buy
28,295
+2,482
+10% +$68.9K 0.01% 718
2023
Q4
$739K Sell
25,813
-2,425
-9% -$71.2K 0.01% 776
2023
Q3
$1.05M Sell
28,238
-250
-0.9% -$9.55K 0.02% 677
2023
Q2
$1.11M Sell
28,488
-5,994
-17% -$235K 0.02% 672
2023
Q1
$1.26M Sell
34,482
-1,010
-3% -$31.9K 0.02% 616
2022
Q4
$1.09M Buy
+35,492
New +$1.1M 0.02% 662

Other funds holding RTO

Oppenheimer Asset Management's RTO Position: Q2 2025 in Review

Oppenheimer Asset Management sold out of Rentokil (RTO) in Q2 2025, closing a stake of 12,970 shares — an estimated $297K sold.

Oppenheimer Asset Management first reported a position in RTO in Q4 2022 and held it in 10 quarters. The position peaked at $1.26M in Q1 2023. 205 funds tracked by Wall St. Rank hold RTO as of Q2 2025.

  • Oppenheimer Asset Management reported no remaining Rentokil position as of Q2 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 12,970 Rentokil shares in Q2 2025, an estimated $297K.
  • Oppenheimer Asset Management first reported a position in Rentokil in Q4 2022 and held it in 10 quarters.
  • Oppenheimer Asset Management's Rentokil position peaked at $1.26M in Q1 2023.
  • 205 funds tracked by Wall St. Rank held Rentokil as of Q2 2025.

Based on Oppenheimer Asset Management's 13F filing for Q2 2025, filed 31 Jul 2025.